Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis - 14/02/22
Doi : 10.1016/j.jinf.2021.09.003
Ling Zuo a, 1, Guangyu Ao b, 1, Yushu Wang c, d, 1, Ming Gao c, Xin Qi e, ⁎ 
a Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
b Department of Nephrology, Chengdu First People's Hospital, Chengdu, Sichuan, China
c Department of Cardiology, Chengdu First People's Hospital, Chengdu, Sichuan, China
d Chengdu West China Clinical Research Center Co., Ltd., Chengdu, China
e Department of Neurology, The Affiliated Hospital of Southwest Jiaotong University & The Third People's Hospital of Chengdu, No.82 North Qinglong Street, Qingyang District, Sichuan 610016, China
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | All studies compared Bamlanivimab monotherapy vs. control group. |
• | A total of 8 studies comprising of 13,573 adult patients with COVID-19 were included. |
• | Outcomes suggested Bamlanivimab improved hospitalization and mortality rates. |
Keywords : COVID-19, Bamlanivimab, Mortality, SARS-Cov-2
Plan
© 2021
Publié par Elsevier Masson SAS.
Vol 84 - N° 2
P. 248-288 - février 2022 Retour au numéro
Article précédent
- Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: A prospective cohort study of vaccinated and unvaccinated healthcare workers
- Alessandra Luna-Muschi, Igor C. Borges, Elizabeth de Faria, Antonio S. Barboza, Fernando L. Maia, Mariana D. Leme, Ana Rubia Guedes, Maria Cassia Mendes-Correa, Esper G. Kallas, Aluísio C. Segurado, Alberto J.S. Duarte, Carolina S. Lazari, Pamela S. Andrade, Flávia C.S. Sales, Ingra M. Claro, Ester C. Sabino, Anna S. Levin, Silvia F. Costa
- Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites
- Shizheng Qiu, Donghua Wang, Yu Zhang, Yang Hu
Bienvenue sur EM-consulte, la référence des professionnels de santé.